Commentary: locating the restriction point

Abstract Attempts to map the Restriction Point in the mammalian cell cycle typically involve stimulating quiescent cells with mitogens for increasing intervals, removing the stimulus and then determining the proportion of cells that reach S phase at some point later. This “fixed point” estimate assu...

Full description

Bibliographic Details
Main Author: Robert F. Brooks
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Cell Division
Subjects:
Online Access:https://doi.org/10.1186/s13008-023-00085-8
_version_ 1811165785866895360
author Robert F. Brooks
author_facet Robert F. Brooks
author_sort Robert F. Brooks
collection DOAJ
description Abstract Attempts to map the Restriction Point in the mammalian cell cycle typically involve stimulating quiescent cells with mitogens for increasing intervals, removing the stimulus and then determining the proportion of cells that reach S phase at some point later. This “fixed point” estimate assumes that further cell cycle commitment ceases as soon as the stimulus is removed. In fact, kinetic analysis shows that the probability of cell cycle commitment does not fall back to its initial low value, immediately after a pulse of mitogens, but may instead remain slightly elevated for some while afterwards, compared to the starting quiescent population. Thus, cells entering S phase after a brief exposure to mitogens are not those that pass the Restriction Point early. Rather, they represent cells that continue on to S phase as a result of this residual, low probability of cell cycle commitment. Instead, the mitogen-regulated process(es) affecting the probability of cell cycle commitment are much closer to the start of S phase itself. Since the acquisition of (apparent) mitogen independence is such a poor indicator of the timing of cell cycle commitment, it is argued that a better measure is the point of insensitivity to CDK4,6 inhibitors such as palbociclib, which indicates when hyperphosphorylation of the Retinoblastoma Protein, RB, ceases to be dependent on mitogen-signalling pathways regulating CDK4,6/cyclin D activity.
first_indexed 2024-04-10T15:42:48Z
format Article
id doaj.art-9d126629450c4f398c82f1d26d2d8a51
institution Directory Open Access Journal
issn 1747-1028
language English
last_indexed 2024-04-10T15:42:48Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Cell Division
spelling doaj.art-9d126629450c4f398c82f1d26d2d8a512023-02-12T12:17:53ZengBMCCell Division1747-10282023-02-011811610.1186/s13008-023-00085-8Commentary: locating the restriction pointRobert F. Brooks0Molecular and Clinical Sciences Research Institute, St George’s University of LondonAbstract Attempts to map the Restriction Point in the mammalian cell cycle typically involve stimulating quiescent cells with mitogens for increasing intervals, removing the stimulus and then determining the proportion of cells that reach S phase at some point later. This “fixed point” estimate assumes that further cell cycle commitment ceases as soon as the stimulus is removed. In fact, kinetic analysis shows that the probability of cell cycle commitment does not fall back to its initial low value, immediately after a pulse of mitogens, but may instead remain slightly elevated for some while afterwards, compared to the starting quiescent population. Thus, cells entering S phase after a brief exposure to mitogens are not those that pass the Restriction Point early. Rather, they represent cells that continue on to S phase as a result of this residual, low probability of cell cycle commitment. Instead, the mitogen-regulated process(es) affecting the probability of cell cycle commitment are much closer to the start of S phase itself. Since the acquisition of (apparent) mitogen independence is such a poor indicator of the timing of cell cycle commitment, it is argued that a better measure is the point of insensitivity to CDK4,6 inhibitors such as palbociclib, which indicates when hyperphosphorylation of the Retinoblastoma Protein, RB, ceases to be dependent on mitogen-signalling pathways regulating CDK4,6/cyclin D activity.https://doi.org/10.1186/s13008-023-00085-8Restriction pointQuiescenceMitogen stimulationRetinoblastoma protein (RB)Cyclin-dependent kinases 4 and 6 (CDK4,6)Cyclin-dependent kinase 2 (CDK2)
spellingShingle Robert F. Brooks
Commentary: locating the restriction point
Cell Division
Restriction point
Quiescence
Mitogen stimulation
Retinoblastoma protein (RB)
Cyclin-dependent kinases 4 and 6 (CDK4,6)
Cyclin-dependent kinase 2 (CDK2)
title Commentary: locating the restriction point
title_full Commentary: locating the restriction point
title_fullStr Commentary: locating the restriction point
title_full_unstemmed Commentary: locating the restriction point
title_short Commentary: locating the restriction point
title_sort commentary locating the restriction point
topic Restriction point
Quiescence
Mitogen stimulation
Retinoblastoma protein (RB)
Cyclin-dependent kinases 4 and 6 (CDK4,6)
Cyclin-dependent kinase 2 (CDK2)
url https://doi.org/10.1186/s13008-023-00085-8
work_keys_str_mv AT robertfbrooks commentarylocatingtherestrictionpoint